Skip to main content

Genetics Startups

Updated November 2026

Companies in the genetics sector developing innovative solutions and technologies.

Explore 352 recently funded genetics companies with verified founder contact information and fundraising data.

Total Companies
352
Total Funding
$1.2B
Avg Funding
$48.3M
Global Reach
7
countries

Top Cities for Genetics

Dallas
Reykjavík
Minneapolis
South San Francisco
Basel
San Francisco

Recently Funded Companies

Export
Dallas, United States

Warhound develops genetically optimized, cybernetically equipped working dogs for defense.

$200.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Reykjavík, Iceland

Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.

$21.5M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Minneapolis, United States

Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost

$1.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.

$8.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.

$134.7M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.

$93.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.

$93.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

$50.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.

$93.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Estuary Biotherapeutics is a biotechnology company developing genetic medicines for serious kidney diseases.

$93.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Probably Genetic is changing the lives of patients living with severe, complex diseases.

$12.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Paris, France

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

$1.1M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Arboretum LifeSciences develops genetic testing, research registry, and precision medicine programs for common diseases.

$30.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Paris, France

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

$26.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Long Island City, United States

Biotia is a health tech startup offering AI-based solutions to diagnose and control infectious disease.

$9.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.

$2.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Mountain View, United States

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

$10.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong

Connexus Therapeutics is a private, venture-backed biotechnology startup.

$5.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Alvara Therapeutics develops small-molecule therapies for chronic kidney disease.

$646K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Flomics mines the nucleic acids in your fluids to create affordable, non-invasive and accurate diagnostics

$1.1M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.

$3.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Charlottesville, United States

Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.

$10.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.

$275.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Yngvi Bio develops protein-based biopesticides for targeted agricultural pest control.

$1.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

New Haven, United States

Cloverleaf Bio develops an RNA therapeutic platform for oncology.

$33.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 352 companies

About the Genetics Startup Ecosystem

The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Genetics

Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Genetics Funding Breakdown

Here is how funding is distributed among the 352 genetics companies tracked in the VCBacked database.

Average Funding
$48.3M
Total Funding Tracked
$1.2B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Genetics

1.San Francisco
5 companies$384.0M
2.South San Francisco
3 companies$333.0M
3.Paris
2 companies$27.1M
4.Copenhagen
2 companies$2.2M
5.Dallas
1 companies$200.0M

Related Industries

Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Genetics Startups?

Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked